Lilly(Eli) & Company

NYSE: LLY
$902.71
-$10.04 (-1.1%)
Closing Price on September 6, 2024

LLY Chart and Intraday Price

LLY Company Data

Asset Type Stock
Exchange NYSE
Currency USD
Country USA
Sector LIFE SCIENCES
Industry PHARMACEUTICAL PREPARATIONS
Address LILLY CORPORATE CTR, DROP CODE 1094, INDIANAPOLIS, IN, US
Fiscal Year End December
Latest Quarter 12/31/2023
Market Cap 743,142.26M USD
Shares Outstanding 950,164,000
Eli Lilly and Company is a global leader in pharmaceuticals, focusing on discovering, developing, and marketing a wide range of human medications. With a rich history dating back to 1876 and headquartered in Indianapolis, Indiana, it offers treatments for diabetes, including a comprehensive lineup of insulin products, and type 2 diabetes medications like Jardiance and Trulicity. The company also has a strong presence in oncology, rheumatoid arthritis, dermatology, mental health, and more, with notable products such as Alimta for cancer and Cymbalta for depression. Eli Lilly collaborates with various industry partners to enhance its product offerings.

LLY Articles

Unless you have been living under the rock, you’d have heard of Nvidia’s (NASDAQ: NVDA) success story. All investors want a bite of this big business and those who missed out are now trying to...
Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 589.06% and currently trading at $911.01. The company has been around since 1876 and the...
Capitalizing on the popularity of weight-loss drugs like Wegovy and Zepbound, Hims & Hers Health (NYSE:HIMS) has exploited a loophole in Food & Drug Administration regulations to bring to...
The surge in interest investors have displayed for companies delivering weight loss drugs has been impressive. Indeed, the growth various weight loss drugs have seen is notable, with GLP-1 agonists...
Remember when a stock becoming valued at $1 trillion was a big thing? The first company to do so was Apple (NASDAQ:AAPL) back in 2018. Now there are a half dozen trillion-dollar stocks. And while a...
The July Consumer Price Index (CPI) appears to progress towards the Federal Reserve’s 2% inflation target rate. Consumer prices have started cooling after rising a modest 2.9% in the 12 months...
Holding a promising future due to recent success in the obesity drug market, Eli Lilly (NYSE:LLY) appears to be bound for continued gains. An impressive move higher in LLY stock, with the company’s...
Long-term stocks, or those that are meant to be held for over a year, let investors ignore daily market fluctuations. Known as “sleep-at-night” stocks, they remain reliable in the face of...
Eli Lilly (NYSE: LLY) stock has been a winner for investors of late, owing largely to strong consumer demand for obesity drugs. Shares have ballooned by nearly 60% year-to-date, while investors have...
Wall Street expectations for where Eli Lilly stock is headed this year vary considerably, but some analysts still have faith.
ETFs have become an exceptionally popular choice for investors seeking diversification and exposure to large market segments. Thematic ETFs, like the iShares S&P 500 Value ETF (NYSE: IVE),...
Many investors choose to invest in ETFs or mutual funds, which provide immediate diversification. These versatile “baskets” of securities offer a convenient way to gain exposure to many different...
Diversification is key in today’s investing world. Exchange-traded funds, or ETFs, offer a convenient and affordable way to achieve this. Think of them as baskets filled with a variety of stocks....
ETFs and mutual funds can both be powerful tools for investors seeking diversification. Both of these investment vehicles hold baskets of securities. When you purchase them, you’re also purchasing...
SCHD and VOO are two very popular ETFs for investors looking to diversify quickly. Like all ETFs, these two investment vehicles hold a “bucket” of stocks. However, the stocks they hold are very...